Carteolol is a non-selective beta-adrenoceptor antagonist. Carteolol induces apoptosis via a caspase activated and mitochondrial-dependent pathway. Carteolol can be used for glaucoma research[1].
Molecular Weight:
292.37
CAS Number:
[51781-06-7]
Formula:
C16H24N2O3
Target:
Adrenergic Receptor,Bcl-2 Family,Caspase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted